| Isotechnika, Vifor Pharma enter development and commercialization license deal - Pharmaceutical Business Review |
|
|
Pharmaceutical Business Review As per the agreement Vifor Pharma is granted an exclusive license for the Isotechnika's drug, voclosporin, to treat lupus and all proteinuric nephrology indications (the Vifor Pharma License). The Vifor Pharma License is for the US and other regions ... Isotechnika Enters Into Development and Commercialization License Agreement |